These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10798750)

  • 1. Graft-protective role of high pretransplantation IgA-anti-Fab autoantibodies: confirmatory evidence obtained in more than 4000 kidney transplants. The Collaborative Transplant Study.
    Süsal C; Döhler B; Opelz G
    Transplantation; 2000 Apr; 69(7):1337-40. PubMed ID: 10798750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
    Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF
    Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretransplant serum IgA concentration and IgA-anti-Fab autoantibody activity as prognostic indicators of kidney graft survival.
    Süsal C; Dörr C; Groth J; May G; Opelz G
    Transpl Int; 1994; 7 Suppl 1():S586-9. PubMed ID: 11271315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early post-transplant immune monitoring can predict long-term kidney graft survival: soluble CD30 levels, anti-HLA antibodies and IgA-anti-Fab autoantibodies.
    Amirzargar MA; Amirzargar A; Basiri A; Hajilooi M; Roshanaei G; Rajabi G; Mohammadiazar S; Solgi G
    Hum Immunol; 2014 Jan; 75(1):47-58. PubMed ID: 24055694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre- and Posttransplant IgA Anti-Fab Antibodies to Predict Long-term Kidney Graft Survival.
    Amirzargar MA; Amirzargar A; Basiri A; Hajilooi M; Roshanaei G; Rajabi G; Solgi G
    Transplant Proc; 2015 May; 47(4):1110-3. PubMed ID: 26036531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against MICA antigens and kidney-transplant rejection.
    Zou Y; Stastny P; Süsal C; Döhler B; Opelz G
    N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretransplant serum IgA concentration and IgA-anti-Fab autoantibody activity in living donor renal transplant recipients: a pilot study.
    Kim MS; Kim YS; Kim SI; Lee JW; Moon JI; Park K
    Transplant Proc; 1998 Nov; 30(7):2977-8. PubMed ID: 9838314
    [No Abstract]   [Full Text] [Related]  

  • 8. IgA class antibodies and flow cytometric cross-matching in renal transplantation.
    Doran TJ; Süsal C; Opelz G; Geczy AF
    Transplantation; 1999 Jan; 67(2):309-14. PubMed ID: 10075600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney graft failure and presensitization against HLA class I and class II antigens.
    Süsal C; Opelz G
    Transplantation; 2002 Apr; 73(8):1269-73. PubMed ID: 11981420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excellent kidney graft survival in patients with high pretransplant serum IgA concentrations and IgA-anti-Fab autoantibody activity.
    Süsal C; Wiesel M; Staehler G; Groth J; May G; Opelz G
    Transplant Proc; 1995 Feb; 27(1):1072-4. PubMed ID: 7878810
    [No Abstract]   [Full Text] [Related]  

  • 12. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
    Süsal C; Döhler B; Opelz G
    Hum Immunol; 2009 Aug; 70(8):569-73. PubMed ID: 19375472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of protective anti-Fab autoantibodies in kidney graft recipients.
    Süsal C; Groth J; Tanzi-Fetta RF; Kirste G; Doerr C; Terness P; May G; Staehler G; Opelz G
    Transplant Proc; 1992 Dec; 24(6):2523-6. PubMed ID: 1465853
    [No Abstract]   [Full Text] [Related]  

  • 14. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presensitization and HLA match influence the predictive power of pretransplant serum IgA and IgA-anti-Fab autoantibodies in kidney graft recipients.
    Süsal C; Wiesel M; Schönemann C; Groth J; Carl S; Staehler G; May G; Opelz G
    Transplant Proc; 1997; 29(1-2):1444-6. PubMed ID: 9123373
    [No Abstract]   [Full Text] [Related]  

  • 16. Different appearance and pathogenic roles of serum IgA against autologous IgG Fc and Fab in patients with IgA nephropathy.
    Yashiro M; Muso E; Yoshida H; Shimada T; Matsushima M; Sawanishi K; Sugiyama T; Kawai C
    Nihon Jinzo Gakkai Shi; 1991 May; 33(5):497-506. PubMed ID: 1895549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A natural IgA-anti-F(ab')2gamma autoantibody occurring in healthy individuals and kidney graft recipients recognizes an IgG1 hinge region epitope.
    Terness P; Navolan D; Moroder L; Siedler F; Weyher E; Kohl I; Dufter C; Welschof M; Drugarin D; Schneider F; Opelz G
    J Immunol; 1996 Nov; 157(9):4251-7. PubMed ID: 8892664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of anti-IgG autoantibodies in kidney transplantation.
    Süsal C; Guo ZG; Terness P; Opelz G
    Immunol Lett; 1990 Nov; 26(2):121-5. PubMed ID: 2269482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplant IgA-anti-hinge and IgA-anti-Fab autoantibody activity is associated with good kidney graft survival.
    Süsal C; Kröpelin M; Wiesel M; Staehler G; Groth J; May G; Opelz G
    Transplant Proc; 1995 Oct; 27(5):2663-5. PubMed ID: 7482869
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry.
    Takemoto S; Terasaki PI; Cecka JM; Cho YW; Gjertson DW
    N Engl J Med; 1992 Sep; 327(12):834-9. PubMed ID: 1508242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.